Microsomal epoxide hydrolase of rat liver is a subunit of the anti-oestrogen-binding site

被引:28
作者
Mésange, F
Sebbar, M
Kedjouar, B
Capdevielle, J
Guillemot, JC
Ferrara, P
Bayard, F
Delarue, F
Faye, JC [1 ]
Poirot, M
机构
[1] CHU Rangueil, Inst Louis Bugnard, INSERM U397, F-31403 Toulouse 4, France
[2] Sanofi Elf Biorech, Lab Biochim Prot, F-31676 Labege, France
关键词
D O I
10.1042/bj3340107
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A tritiated photoaffinity labelling analogue of tamoxifen, [(2-azido-4-benzyl)-phenoxy]-N-ethylmorpholine (azido-MBPE), was used to identify the anti-oestrogen-binding site (AEBS) in rat liver tissue [Poirot, Chailleux, Fargin, Bayard and Faye (1990) J, Biol, Chem, 265, 17039-17043]. UV irradiation of rat liver microsomal proteins incubated with tritiated azido-MBPE led to the characterization of two photolabelled proteins of molecular masses 40 and 50 kDa. The amino acid sequences of proteolytic products from the 50 kDa protein were identical with those from rat microsomal epoxide hydrolase (mEH). Treatment of hepatocytes with anti-sense mRNA directed against mEH abolished AEBS in these cells. In addition we found that tamoxifen and N-morpholino-2-[4-(phenylmethyl)phenoxy] ethanamine, a selective ligand of AEBS, were potent inhibitors of the catalytic hydration of styrene oxide by mEH. However, functional overexpression of the human mEH did not significantly modify the binding capacity of [H-3]tamoxifen. Taken together, these results suggest that the 50 kDa protein, mEH, is necessary but not sufficient to reconstitute AEBS.
引用
收藏
页码:107 / 112
页数:6
相关论文
共 48 条
[1]   MONOCLONAL-ANTIBODIES AGAINST HUMAN-LIVER CYTOCHROME-P-450 [J].
BEAUNE, P ;
KREMERS, P ;
LETAWEGOUJON, F ;
GIELEN, JE .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (19) :3547-3552
[2]   EVALUATION OF ESTROGEN-RECEPTOR, ANTIESTROGEN BINDING-SITES AND CALMODULIN FOR ANTIESTROGEN RESISTANCE OF 2 CLONES DERIVED FROM THE MCF-7 BREAST-CANCER CELL-LINE [J].
BORRAS, M ;
JIN, L ;
BOUHOUTE, A ;
LEGROS, N ;
LECLERCQ, G .
BIOCHEMICAL PHARMACOLOGY, 1994, 48 (11) :2015-2024
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]  
BRANDES LJ, 1988, CANCER RES, V48, P3954
[5]   A DIPHENYLMETHANE DERIVATIVE SELECTIVE FOR THE ANTI-ESTROGEN BINDING-SITE MAY HELP DEFINE ITS BIOLOGICAL ROLE [J].
BRANDES, LJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 124 (01) :244-249
[6]   A DIPHENYLMETHANE DERIVATIVE SPECIFIC FOR THE ANTIESTROGEN BINDING-SITE FOUND IN RAT-LIVER MICROSOMES [J].
BRANDES, LJ ;
HERMONAT, MW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 123 (02) :724-728
[7]   THE ANTIPROLIFERATIVE PROPERTIES OF TAMOXIFEN AND PHENOTHIAZINES MAY BE MEDIATED BY A UNIQUE HISTAMINE-RECEPTOR (QUESTIONABLE-H-3) DISTINCT FROM THE CALMODULIN-BINDING SITE [J].
BRANDES, LJ ;
BOGDANOVIC, RP ;
CAWKER, MD ;
BOSE, R .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1986, 18 (01) :21-23
[8]   CHARACTERIZATION OF THE MEMBRANOUS ANTIESTROGEN BINDING-PROTEIN .1. PARTIAL-PURIFICATION OF THE PROTEIN IN ITS ACTIVE STATE [J].
CHAILLEUX, C ;
POIROT, M ;
MESANGE, F ;
BAYARD, F ;
FAYE, JC .
JOURNAL OF RECEPTOR RESEARCH, 1994, 14 (01) :23-35
[9]   TAMOXIFEN AND ITS ACTIVE METABOLITE INHIBIT GROWTH OF ESTROGEN RECEPTOR-NEGATIVE MDA-MB-435 CELLS [J].
CHARLIER, C ;
CHARIOT, A ;
ANTOINE, N ;
MERVILLE, MP ;
GIELEN, J ;
CASTRONOVO, V .
BIOCHEMICAL PHARMACOLOGY, 1995, 49 (03) :351-358
[10]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2